Blood Chap 10

Embed Size (px)

Citation preview

  • 8/3/2019 Blood Chap 10

    1/76

    Chapter 10

  • 8/3/2019 Blood Chap 10

    2/76

    Bone marrowBlood cells

    Plasma

  • 8/3/2019 Blood Chap 10

    3/76

  • 8/3/2019 Blood Chap 10

    4/76

    Whole blood consists of formed elementssuspended in a liquid component.

    5-6 liters total blood volume in an adult

    8% of total body weight

    Slightly alkaline: pH 7.35-7.45

    Temp.: 38 celsius

  • 8/3/2019 Blood Chap 10

    5/76

    Bone marrow

    4% - 5% of total body weight

    Contained within the spongy bones and centralcavity of long bones

  • 8/3/2019 Blood Chap 10

    6/76

    Red marrow Site of active cell formation

    Major blood producing organ (hematopoiesis)

    Yellow marrow Constitutes inactive areas composed mainly of fat

    Stem cells Free, primitive cells present in bone marrow

    Differentiates into mature blood cells

  • 8/3/2019 Blood Chap 10

    7/76

    Blood cells

    Hematocrit refers to the percentage of total bloodvolume composed of cells.

    Normal value approximately 45%

    Whole blood contains 3 types of mature blood cells

    Erythrocytes Leukocytes

    Thrombocytes

  • 8/3/2019 Blood Chap 10

    8/76

  • 8/3/2019 Blood Chap 10

    9/76

    ERYTHROCYTES (RBCs)

    Average total RBC count: 5million cells/mm3of blood

    Erythrocyte major cellular element of circulating blood

    Bi-concave disks that normally are about 7mm indiameter and containing hemoglobin confinedwithin a plasma membrane

  • 8/3/2019 Blood Chap 10

    10/76

  • 8/3/2019 Blood Chap 10

    11/76

  • 8/3/2019 Blood Chap 10

    12/76

    Reticulocytes Immature erythrocytes

    Released prematurely from marrow to circulation

    under conditions necessitating rapid blood cellproduction (compensatory mechanism)

  • 8/3/2019 Blood Chap 10

    13/76

    Hemoglobin Consist of an iron-containing pigment and a simple

    protein

    95% of the erythrocyte mass

    Has the ability to bind oxygen loosely andreversibly

    Called oxyhemoglobin if combined with oxygen

    15g. Of hemoglobin per 100ml of blood

  • 8/3/2019 Blood Chap 10

    14/76

    LEUKOCYTES (WBCs)

    5,000-10,000 cells/cubic mm of blood -Average total WBC count

    2 Major Types:

    1. Granular Leukocytes

    Produced in bone marrow Granulocytes comprise 70% of all WBCs

  • 8/3/2019 Blood Chap 10

    15/76

    3 Types of Granulocytes Neutrophils

    Pink stain

    Multi-lobed nucleus

    Eosinophils

    Blue red nucleus

    Basophils Dark blue stain

  • 8/3/2019 Blood Chap 10

    16/76

  • 8/3/2019 Blood Chap 10

    17/76

  • 8/3/2019 Blood Chap 10

    18/76

  • 8/3/2019 Blood Chap 10

    19/76

    2. Mononuclear leukocytes2 groups

    Lymphocytes Produced in bone marow

    Undergo differentiation in lymph tissue Comprise 30% of leukocytes Large purple nucleus

    Monocytes Produced in bone marrow Transform into mature forms called macrophages on

    release into tissues Comprise 5% of total leukocytes Largest WBCs

  • 8/3/2019 Blood Chap 10

    20/76

  • 8/3/2019 Blood Chap 10

    21/76

  • 8/3/2019 Blood Chap 10

    22/76

  • 8/3/2019 Blood Chap 10

    23/76

    THROMBOCYTES Normal platelet count is:

    150,000 to 450,000/mm3 of blood

    Thrombocytes are formed from fragments ofmembrane and cytoplasm from very largecells in bone marrow, lung, and spleen calledmegakaryocytes

    Normal lifespan of thrombocytes:

    7-14 days

  • 8/3/2019 Blood Chap 10

    24/76

  • 8/3/2019 Blood Chap 10

    25/76

  • 8/3/2019 Blood Chap 10

    26/76

    Liquid portion of whole blood remaining afterblood cells are removed

    55% of blood volume

    Contains large quantities of organic andinorganic substances

    Serum Fluid remaining when plasma is allowed to clot

  • 8/3/2019 Blood Chap 10

    27/76

    PLASMA PROTEINS Albumin

    Largest of plasma proteins, produced in the liver

    Globulins Gamma globulins

    Consists of antibodies known as immunoglobulins

    Alpha and beta fractions

    Clotting factors, produced in the liver and transport proteins

    Fibrinogen High-molecular wt. protein important in blood clotting

  • 8/3/2019 Blood Chap 10

    28/76

    FACTOR SYNONYMS NORMAL PLASMACONCENTRATIONS(mg/dl)I Fibrinogen 200 400

    II Prothrombin 10III Tissue thromboplastin,

    tissue factor0

    IV Calcium ion 4 5

    V Pro accelerin, labile factor 1

  • 8/3/2019 Blood Chap 10

    29/76

    FACTOR SYNONYMS NORMAL PLASMACONCENTRATIONS(mg/dl)VII Serum prothrombin

    conversion

    accelerator(SPCA),stable factor

    0.05

    VIII Antihemophilic factor 1 - 2

    IX Christmas factor 0.3

    X Stuart-Power factor 1

    XI Plasmathromboplastinantecedent (PTA)

    0.5

  • 8/3/2019 Blood Chap 10

    30/76

    FACTOR SYNONYMS NORMAL PLASMACONCENTRATIONS(mg/dl)XII Hageman factor 3

    XIII Fibrin stabilizingfactor (FSF)

    1 2

    Prekallikrein Fletcher factor 5

    High

    molecularweightkininogen

    Fitzgerald,

    Flaujeac, Williamsfactor, contactactivation cofactor

    6

  • 8/3/2019 Blood Chap 10

    31/76

  • 8/3/2019 Blood Chap 10

    32/76

    Transport oxygen absorbed from lungs andnutrients absorbed from the GIT to body cellsfor cellular metabolism

    Transport waste products from tissues toexcretory organs

    Aid in chemical, acid-base, and thermalregulation of the body

    Transport hormones and other substancesinternally secreted to their tissue sites ofaction

  • 8/3/2019 Blood Chap 10

    33/76

    Aid in defense against infection through theactons of antibodies and phagocytes

    Aid in regulation of extracellular fluid volume

    Promoting hemostasis through the arrest ofbleeding blood clot formation, followed by

    clot dissolution

  • 8/3/2019 Blood Chap 10

    34/76

    Produces all blood cells During hematopoiesis:

    Stem cells in the bone marrow divide into themyelocyte stem cell line and lymphiod stem cell line

    transform into committed precursors,

    and eventually differentiate into mature blood cells

  • 8/3/2019 Blood Chap 10

    35/76

    ERYTHROCYTES Normal production is stimulated by

    erythropoietin and requires several nutrients: Iron

    Folic acid Pyridoxine (vit. b complex) Ascorbic acid

    Transport O2 from lungs to tissues

    Ave. lifespan is 120 days

  • 8/3/2019 Blood Chap 10

    36/76

  • 8/3/2019 Blood Chap 10

    37/76

    LEUKOCYTESDefend the body against invasion by infectious and

    parasitic organisms through phagocytosis andantibody production

    Neutrophils Arrive early at the site of inflammatory reaction

    Increase in number with the onset of infection

  • 8/3/2019 Blood Chap 10

    38/76

    Eosinophils and basophils Alter blood supply to tissues and help mobilize body

    defenses Eosinophils increases in allergies and infections of

    parasitic worms Basophils - Contain and release potent biologic

    materials: Histamine, serotonin, heparin Makes blood vessels leaky and attracts other WBCs to

    inflammation site

    Monocytes Largest non-granular leukocytes

    Phagocytizes large foreign particles, cell fragments,necrotic tissue

  • 8/3/2019 Blood Chap 10

    39/76

    LymphocytesProduce substances that aid in attacking foreign cells

    and substances

    B lymphocytes

    Produce antibodies

    T lymphocytes Kill foreign cells directly or release lymphokines

    Natural killer cells (NK) Defend against microorganisms and some types of

    malignant cells

  • 8/3/2019 Blood Chap 10

    40/76

    THROMBOCYTESHelp control bleeding by:

    Aggregating and adhering to sites of vascularinjury, forming a plug that temporarily stopsbleeding

    Releasing biochemical substances thatactivate coagulation factors in plasma to forma stable fibrin clot

  • 8/3/2019 Blood Chap 10

    41/76

    Part of the ECF of the body and provides amedium for circulation of blood cells

    Plasma proteins

    1. Albumin Causes osmotic pressure at the capillary

    membrane

    Prevents fluid from leaking out of the capillariesinto the interstitial spaces

    Process called colloid osmotic pressure

  • 8/3/2019 Blood Chap 10

    42/76

    2. Globulins Alpha and beta globulins

    Transport of other substances by combining withthem

    Acting as substrates for formation of othersubstances Transporting proteins from part of the body to

    another

    Gamma globulins Protect body against infections Antibodies that resist infection and toxicity

  • 8/3/2019 Blood Chap 10

    43/76

    3. Fibrinogen

    High molecular weight protein

    One of the essential factors in thecoagulation process

    Thrombin acts on fibrinogen to form thereticulum of the clot

  • 8/3/2019 Blood Chap 10

    44/76

    Constituent substances in plasma provide for: Blood coagulation

    Vascular phase vessel constriction Platelet phase aggregation at bleeding site

    Coagulation phase - clot formation

    Maintenance of acid-base balance Clot lysis

    Fibrinolytic system Plasminogen

    Fibrinolysis Transportation of nutritional and hormonal

    substances

  • 8/3/2019 Blood Chap 10

    45/76

  • 8/3/2019 Blood Chap 10

    46/76

    Platelet plug

    forms

    Vascular

    spasm occur

    Coagulation

    events occur

  • 8/3/2019 Blood Chap 10

    47/76

    Antigen Substance recognized by body as foreign Stimulates immune system to release antibodies E.g. foreign substances, part of bacteria

    Antibodies Recognizers Present in the plasma that attach to RBCs

    Agglutination Binding of antibodies causing RBCs to clump

  • 8/3/2019 Blood Chap 10

    48/76

    Based on which of 2 antigens A or B a prsoninherits

    Type O Absence of both antigens

    Type AB Presence of both antigens

    Type A or Type B Presence of either A or B antigen

  • 8/3/2019 Blood Chap 10

    49/76

    Bloodgroup RBCantigens Plasmaantibodies Blood thatcan bereceivedAB A

    BNone A, B, AB, O

    Universalrecipient

    B B Anti-A B, O

    A A Anti-B A, OO None Anti-A

    Anti-BOUniversal

    donor

  • 8/3/2019 Blood Chap 10

    50/76

    One of the 8 antigens identified with Rhesusmonkeys, but later discovered in humans

    Rh+

    Rh-

    Hemolysis

  • 8/3/2019 Blood Chap 10

    51/76

  • 8/3/2019 Blood Chap 10

    52/76

    Before birth:

    liver, spleen

    7 months:

    Red marrow

    Throughout

    life:

    Red marrow

  • 8/3/2019 Blood Chap 10

    53/76

    Whole Blood Replacement of RBCs and plasma volume to raise Hgb and

    Hct levels Not commonly used due to fluid overload

    PRBCs Preferred replacement of RBCs and plasma volume to raise

    Hgb and Hct levels RBCs without plasma volume For severe symptomatic anemia or acute blood loss

    Fresh frozen plasma Replacement of plasma without RBCs or platelets Contains most coagulation factors except platelets Used to control bleeding caused by deficiency in clotting

    factors

  • 8/3/2019 Blood Chap 10

    54/76

    Platelets Replacement of platelets

    Used to treat severe or symptomaticthrombocytopenia

    Albumin A hyperosmolar solution prepared from plasma that

    expands vascular volume

    Used to treat hypovolemic shock orhypoalbumenemia

  • 8/3/2019 Blood Chap 10

    55/76

  • 8/3/2019 Blood Chap 10

    56/76

  • 8/3/2019 Blood Chap 10

    57/76

    One of the most common blood diseasesworldwide is anemia, which is characterizedby an abnormally low number of red bloodcells or low levels of hemoglobin.

    One of the major symptoms of anemia isfatigue, due to the failure of the blood tocarry enough oxygen to all of the tissues.

  • 8/3/2019 Blood Chap 10

    58/76

    The most common type of anemia occurs because the marrow fails to produce

    sufficient red blood cells.

    When insufficient iron is available to the bonemarrow, it slows down its production ofhemoglobin and red blood cells.

    The most common causes of iron-deficiencyanemia are certain infections that result ingastrointestinal blood loss and the consequent

    chronic loss of iron. Adding supplemental iron to the diet is often

    sufficient to cure iron-deficiency anemia.

  • 8/3/2019 Blood Chap 10

    59/76

    Some anemias are the result of increaseddestruction of red blood cells, as in the caseof sickle-cell anemia

    a genetic disease most common in persons of

    African ancestry. The red blood cells of sickle-cell patients

    assume an unusual crescent shape, causingthem to become trapped in some bloodvessels, blocking the flow of other blood cellsto tissues and depriving them of oxygen.

  • 8/3/2019 Blood Chap 10

    60/76

  • 8/3/2019 Blood Chap 10

    61/76

    Direct cause: Decrease in RBC Number

    Results from: Sudden hemorrhage

    Lysis of RBCs as a result of bacterial infections

  • 8/3/2019 Blood Chap 10

    62/76

    Direct cause: Decrease in RBC Number

    Results from: Lack of vitamin B12

    Due to lack of intrinsic factor required forabsorption of the vitamin; intrinsic factor is formedby stomach mucosa cells

  • 8/3/2019 Blood Chap 10

    63/76

    Direct cause: Decrease in RBC Number

    Results from: Depression/destruction of bone marrow by cancer,

    radiation, or certain medications

  • 8/3/2019 Blood Chap 10

    64/76

  • 8/3/2019 Blood Chap 10

    65/76

    Some white blood cell diseases arecharacterized by an insufficient number ofwhite blood cells.

    This can be caused by the failure of the bone

    marrow to produce adequate numbers ofnormal white blood cells, or by diseases thatlead to the destruction of crucial white bloodcells.

    These conditions result in severe immunedeficiencies characterized by recurrentinfections.

  • 8/3/2019 Blood Chap 10

    66/76

    Any disease in which excess white blood cells areproduced, particularly immature white bloodcells, is called leukemia, or blood cancer.

    Many cases of leukemia are linked to gene

    abnormalities, resulting in unchecked growth ofimmature white blood cells.

    If this growth is not halted, it often results in thedeath of the patient.

    These genetic abnormalities are not inherited inthe vast majority of cases, but rather occur afterbirth.

  • 8/3/2019 Blood Chap 10

    67/76

    Treatment for leukemia typically involves theuse of chemotherapy, in which strong drugsare used to target and kill leukemic cells,permitting normal cells to regenerate.

    In some cases, bone marrow transplants areeffective. Much progress has been made overthe last 30 years in the treatment of thisdisease.

    In one type of childhood leukemia, more than80 percent of patients can now be cured oftheir disease.

  • 8/3/2019 Blood Chap 10

    68/76

  • 8/3/2019 Blood Chap 10

    69/76

  • 8/3/2019 Blood Chap 10

    70/76

    One disease of the coagulation system ishemophilia, a genetic bleeding disorder in whichone of the plasma clotting factors, usually factorVIII, is produced in abnormally low quantities,resulting in uncontrolled bleeding from minor

    injuries.

    Although individuals with hemophilia are able toform a good initial platelet plug when blood

    vessels are damaged, they are not easily able toform the meshwork that holds the clot firmlyintact.

  • 8/3/2019 Blood Chap 10

    71/76

  • 8/3/2019 Blood Chap 10

    72/76

    Thrombus Clot that develops and persists in an unbroken

    vessel

    May prevent blood flow to the cells beyond the

    blockage

    Embolus Clot (thrombus) that breaks away from the vessel

    wall and floats freely in the blood stream

  • 8/3/2019 Blood Chap 10

    73/76

    RBC 120 days

    WBC 18 to 36 hrs

    Platelets - 7 to 14 days

  • 8/3/2019 Blood Chap 10

    74/76

    Fluosol Main ingredient: perfluorocarbons (PFCs) Depresses the immune system

    Chemically Altered Hemoglobin Harvested hemoglobin from erythrocytes and

    altered

    Artificial RBCs (Neohemocytes) Natural hemoglobin packaged in bubbles made

    from phospholipids and cholesterol

    Hemopure Natural but non human blood substitute Purified hemoglobin extracted from cattle blood

  • 8/3/2019 Blood Chap 10

    75/76

  • 8/3/2019 Blood Chap 10

    76/76

    Bone marrow aspiration and biopsy Complete Blood Cell count

    CBC with Differential WBC count

    Bleeding time

    Clotting time

    Platelet aggregation